Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan, USA.
Nat Med. 2011 Nov 20;17(12):1646-51. doi: 10.1038/nm.2580.
Breast cancer is a heterogeneous disease that has a wide range of molecular aberrations and clinical outcomes. Here we used paired-end transcriptome sequencing to explore the landscape of gene fusions in a panel of breast cancer cell lines and tissues. We observed that individual breast cancers have a variety of expressed gene fusions. We identified two classes of recurrent gene rearrangements involving genes encoding microtubule-associated serine-threonine kinase (MAST) and members of the Notch family. Both MAST and Notch-family gene fusions have substantial phenotypic effects in breast epithelial cells. Breast cancer cell lines harboring Notch gene rearrangements are uniquely sensitive to inhibition of Notch signaling, and overexpression of MAST1 or MAST2 gene fusions has a proliferative effect both in vitro and in vivo. These findings show that recurrent gene rearrangements have key roles in subsets of carcinomas and suggest that transcriptome sequencing could identify individuals with rare, targetable gene fusions.
乳腺癌是一种异质性疾病,具有广泛的分子异常和临床结局。在这里,我们使用配对末端转录组测序来探索一组乳腺癌细胞系和组织中基因融合的全景。我们观察到,个别乳腺癌具有多种表达的基因融合。我们鉴定了两类涉及编码微管相关丝氨酸/苏氨酸激酶(MAST)和 Notch 家族成员的基因重排。MAST 和 Notch 家族基因融合都对乳腺上皮细胞有显著的表型效应。携带 Notch 基因重排的乳腺癌细胞系对 Notch 信号通路的抑制具有独特的敏感性,并且 MAST1 或 MAST2 基因融合的过表达在体外和体内都具有增殖作用。这些发现表明,反复发生的基因重排在肿瘤亚群中具有关键作用,并表明转录组测序可以识别出具有罕见、可靶向基因融合的个体。